GENinCode (GENI)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.25p
   
  • Change Today:
    -0.100p
  • 52 Week High: 9.63
  • 52 Week Low: 2.20
  • Currency: UK Pounds
  • Shares Issued: 286.88m
  • Volume: 120,665
  • Market Cap: £6.45m
  • Beta: 0.06

Deal with Barclays    Trade now with Barclays Stockbrokers

GENinCode Overview

GENinCode is a UK-incorporated company engaged in the risk assessment, prediction and prevention of cardiovascular disease ("CVD"), the leading cause of death worldwide accounting for approximately 18 million deaths annually.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -331.1% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.1 n/a
Pr/Book 5.2  
Latest F'cast
Revenue 51.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GENinCode Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.96 (1.05) (12.71)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.15 (4.14) (8.05)p n/a n/a n/a n/a 0.0%
31-Dec-22 1.43 (5.75) (6.18)p n/a n/a n/a n/a 0.0%
31-Dec-23 2.16 (7.02) (6.97)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GENinCode Company Announcements

Grant of Share Options & PDMR Dealings 26-Mar-2025 07:45 RNS
Holding(s) in Company 06-Mar-2025 14:24 RNS
Holding(s) in Company 05-Mar-2025 15:02 RNS

GENinCode ShareCast News

GENinCode enters collaboration with US Family He... 20-Sep-2024 ShareCast
GENinCode inks partnership with DC's MedStar Hea... 19-Jul-2023 ShareCast
GENinCode prepares for US revenue as California ... 03-Jan-2023 ShareCast

Latest GENinCode Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

GENinCode Market Data

Currency UK Pounds
Share Price 2.25p
Change Today -0.100p
% Change -4.26 %
52 Week High 9.63
52 Week Low 2.20
Volume 120,665
Shares Issued 286.88m
Market Cap £6.45m
Beta 0.06

GENinCode Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.45% below the market average66.45% below the market average66.45% below the market average66.45% below the market average66.45% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
92.8% below the market average92.8% below the market average92.8% below the market average92.8% below the market average92.8% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average
Income Not Available
Growth
46.43% above the market average46.43% above the market average46.43% above the market average46.43% above the market average46.43% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

GENinCode Dividends

No dividends found

Trades for 07-Apr-2025

Time Volume / Share Price
10:20 62,000 @ 2.24p
09:28 4,251 @ 2.24p
08:19 80 @ 2.20p
08:19 245 @ 2.20p
08:01 54,089 @ 2.24p

GENinCode Key Personnel

CEO Matthew Heaton Walls
CFO Paul Andrew Peter Foulger
COO Jordi Puig Gilberte

Top of Page